19 insiders reported 137 Form 4 transactions for Vir Biotechnology, Inc. (VIR) over the past 18 months (most recent 2026-06-10). Recent activity: Coughlin Timothy (Director) Buy 8,000 shares, Coughlin Timothy (Director) Buy 8,000 shares, Napolitano Janet (Director) Sell 3,200 shares, Sabatini Brent (SVP, Chief Accounting Officer) Sell 379 shares, De Backer Marianne (President and CEO) Sell 233,532 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Coughlin Timothy | Director | Buy | 8,000 | $0 |
| 2026-06-10 | Coughlin Timothy | Director | Buy | 8,000 | $0 |
| 2026-06-02 | Napolitano Janet | Director | Sell | 3,200 | $30,240 |
| 2026-06-02 | Sabatini Brent | SVP, Chief Accounting Officer | Sell | 379 | $3,582 |
| 2026-04-30 | De Backer Marianne | President and CEO | Sell | 233,532 | $0 |
| 2026-04-30 | De Backer Marianne | President and CEO | Buy | 233,532 | $0 |
| 2026-04-07 | De Backer Marianne | President and CEO | Sell | 72,559 | $664,350 |
| 2026-04-02 | SATO VICKI L | Director | Sell | 22,000 | $199,617 |
| 2026-03-24 | Sabatini Brent | SVP, Chief Accounting Officer | Sell | 7,711 | $70,324 |
| 2026-03-23 | O'Byrne Jason | EVP & Chief Financial Officer | Sell | 2,500 | $0 |
| 2026-03-23 | O'Byrne Jason | EVP & Chief Financial Officer | Buy | 2,500 | $0 |
| 2026-03-03 | SATO VICKI L | Director | Sell | 21,800 | $207,100 |
| 2026-03-03 | SATO VICKI L | Director | Sell | 200 | $1,996 |
| 2026-02-26 | SATO VICKI L | Director | Buy | 42,377 | $63,142 |
| 2026-02-26 | SATO VICKI L | Director | Sell | 42,177 | $411,226 |
| 2026-02-26 | SATO VICKI L | Director | Sell | 200 | $2,052 |
| 2026-02-26 | O'Byrne Jason | EVP & Chief Financial Officer | Sell | 1,634 | $15,572 |
| 2026-02-26 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell | 3,117 | $29,705 |
| 2026-02-26 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell | 13,700 | $134,534 |
| 2026-02-26 | Eisner Mark | EVP and Chief Medical Officer | Sell | 1,616 | $15,400 |
| 2026-02-26 | Eisner Mark | EVP and Chief Medical Officer | Sell | 1,889 | $18,550 |
| 2026-02-26 | Sabatini Brent | SVP, Chief Accounting Officer | Sell | 1,430 | $13,628 |
| 2026-02-26 | De Backer Marianne | Chief Executive Officer | Sell | 14,762 | $140,682 |
| 2026-02-24 | Eisner Mark | EVP and Chief Medical Officer | Buy | 55,000 | $0 |
| 2026-02-24 | Eisner Mark | EVP and Chief Medical Officer | Sell | 2,089 | $15,563 |
Source: SEC Form 4 filings · as of 2026-06-10